The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress. (2021)
Attributed to:
Validating the PredicTR treatment response classifier for oropharyngeal cancer (PredicTR 2)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.canlet.2020.12.029
PubMed Identifier: 33359448
Publication URI: http://europepmc.org/abstract/MED/33359448
Type: Journal Article/Review
Volume: 501
Parent Publication: Cancer letters
ISSN: 0304-3835